Norris Perne & French’s Amgen AMGN Stock Holding History

Norris Perne & French’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,154	Closed	-$725K	–	141
2020 Q4	$725K	Hold	3,154	–	–	0.07%	88
2020 Q3	$802K	Buy	3,154 +213	+7%	+$52.8K	0.09%	81
2020 Q2	$694K	Buy	+2,941	New	+$671K	0.08%	76
2016 Q1	–	Sell	-1,530	Closed	-$248K	–	144
2015 Q4	$248K	Sell	1,530 -1,200	-44%	-$189K	0.05%	131
2015 Q3	$378K	Buy	2,730 +480	+21%	+$75.7K	0.09%	100
2015 Q2	$345K	Buy	2,250 +50	+2%	+$8.01K	0.07%	111
2015 Q1	$352K	Sell	2,200 -1,300	-37%	-$205K	0.07%	115
2014 Q4	$558K	Hold	3,500	–	–	0.1%	97
2014 Q3	$492K	Hold	3,500	–	–	0.1%	95
2014 Q2	$414K	Sell	3,500 -600	-15%	-$69.5K	0.08%	110
2014 Q1	$506K	Sell	4,100 -1,093	-21%	-$133K	0.1%	95
2013 Q4	$592K	Hold	5,193	–	–	0.11%	105
2013 Q3	$581K	Hold	5,193	–	–	0.12%	106
2013 Q2	$512K	Buy	+5,193	New	+$539K	0.11%	114

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Norris Perne & French's AMGN Position: Q1 2021 in Review

Norris Perne & French sold out of Amgen (AMGN) in Q1 2021, closing a stake of 3,154 shares — an estimated $725K sold.

Norris Perne & French first reported a position in AMGN in Q2 2013 and held it in 14 quarters. The position peaked at $802K in Q3 2020. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.

Norris Perne & French reported no remaining Amgen position as of Q1 2021 after selling out during the quarter.
Norris Perne & French sold 3,154 Amgen shares in Q1 2021, an estimated $725K.
Norris Perne & French first reported a position in Amgen in Q2 2013 and held it in 14 quarters.
Norris Perne & French's Amgen position peaked at $802K in Q3 2020.
2,218 funds tracked by Wall St. Rank held Amgen as of Q1 2021.

Based on Norris Perne & French's 13F filing for Q1 2021, filed 30 Apr 2021.